As we begin 2025, we look back on all of the Huntington’s disease research news and progress the field has made in the last ...

Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community. With your ...

We’re proud to announce AJ Keefe as our last HDBuzz Prize winner of 2024! Our cells are an intricate choreography between ...

Dr. Sarah Hernandez is the Director of Research Programs at the Hereditary Disease Foundation (HDF). She carried out her postdoctoral work with Dr. Leslie Thompson at the University of California, ...

Michael is a Clinical Research Fellow at UCL Huntington's Disease Centre, London, UK. He studies the genetics and cell biology of Huntington’s disease, as well as working on clinical trials. Please ...

A well-studied, widely used class of drugs for heart health may have benefits for Huntington’s disease. A new paper ...

Ed is a neurologist at the National Hospital for Neurology and Neurosurgery, London, UK, and a Professor of Neurology at University College London where he is Associate Director of the Huntington’s ...

Jeff is an Associate Professor in the Department of Neurology at the University of Washington, Seattle, USA. Throughout his academic career, Jeff’s focus has been on better understanding, and ...

Vico Therapeutics recently presented at several conferences to share an interim update on their Phase 1/2a clinical trial testing their drug called VO659, which targets the repeating C-A-Gs in people ...

In the spirit of gratitude, this Giving Tuesday, the HDBuzz editorial team would like to reflect on the unique and transformative role the Huntington’s disease (HD) family community plays in advancing ...